Europe — EMA
Numeta G E
Valine, the active ingredient in Numeta G E, is a parenteral nutrition supplement presented as a solution for intravenous use. It supports metabolic needs in patients requiring comprehensive amino acid nutrition…
Request sourcing
What is Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio?
Valine, the active ingredient in Numeta G E, is a parenteral nutrition supplement presented as a solution for intravenous use. It supports metabolic needs in patients requiring comprehensive amino acid nutrition, particularly in critical care and neonatal settings. GNH USA supplies Numeta G E as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and neonatal intensive care units worldwide.
GNH USA supplies Numeta G E as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and neonatal intensive care units worldwide.
What is Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio used for?
Numeta G E is used as a component of parenteral nutrition regimens for patients with complex metabolic demands.
- Critical care patients: provides essential amino acids to support protein synthesis and nitrogen balance. - Neonates and preterm infants: supplies a balanced amino acid profile for growth and development. - Post‑surgical patients: aids recovery by delivering nutrients when oral intake is limited. - Patients with severe malnutrition: helps restore nutritional status when enteral feeding is not feasible. - Individuals with gastrointestinal disorders that impair absorption: offers an alternative route for amino acid delivery.
What are the side effects of Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio?
Numeta G E may be associated with infusion‑related reactions and metabolic disturbances.
Common Side Effects: - Mild fever or chills during infusion. - Transient increase in blood urea nitrogen. - Slight elevation of liver enzymes. - Local irritation at the catheter site. - Electrolyte shifts such as mild hyperkalemia.
Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Hyperosmolar hyperglycaemic state. - Significant electrolyte imbalance (e.g., severe hypernatremia). - Metabolic acidosis. - Catheter‑related bloodstream infection.
What precautions apply to Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio?
When using Numeta G E, clinicians should assess patient-specific factors and monitor relevant parameters.
- Renal function: adjust infusion rate in patients with impaired kidney function. - Hepatic function: monitor liver enzymes and ammonia levels. - Electrolyte balance: check serum electrolytes before and during therapy. - Glycemic control: observe blood glucose in diabetic or hyperglycaemic patients. - Catheter care: maintain aseptic technique to prevent infection. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.
What does Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio interact with?
Numeta G E can interact with other intravenous solutions and medications administered concurrently.
Major Interactions (Avoid): - High‑dose potassium chloride: may cause dangerous hyperkalemia when combined with the amino acid solution. - Large volumes of dextrose‑containing fluids: increase risk of hyperglycaemia.
Moderate Interaction of - ":" " """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""